Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04398147
Brief Title: Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

First Submitted : May 18, 2020
First Submitted that Met QC Criteria : May 18, 2020
First Posted : May 21, 2020

Last Update Submitted that Met QC Criteria : June 30, 2020
Last Update Posted : July 2, 2020